Skip to main content

Aromatic Heterocycle-Based DPP-IV Inhibitors: Xanthines and Related Structural Types.

Buy Article:

$63.00 + tax (Refund Policy)

Xanthines and xanthine-like DPP-IV inhibitors were first disclosed in 2002. Since then, several dozen accounts of xanthine-based DPP-IV inhibitors have been published. Only a few presentations and journal articles have appeared, with the vast majority of information coming from the patent literature. DPP-IV inhibitors related to the xanthines include purine analogues with other arrangements of the nitrogen atoms in the core structure, imidazoles, uracils, pyrimidines, pyridines, and some fused pyridines. At least one compound derived from the xanthines has advanced into clinical trials, making it likely that these molecules will play a major role in the DPP-IV inhibition arena over the next several years.





No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: ADME; Imidazole; PYRIMIDINE-BASED DPP-IV INHIBITORS; URACIL-BASED DPP-IV INHIBITORS; xanthine mimetics

Document Type: Research Article

Publication date: 01 March 2007

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more